Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Short-term Investments (2021 - 2024)

Opus Genetics (IRD) has disclosed Short-term Investments for 8 consecutive years, with $11000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Short-term Investments fell 89.11% to $11000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $11000.0, a 89.11% decrease, with the full-year FY2022 number at $49000.0, down 77.63% from a year prior.
  • Short-term Investments was $11000.0 for Q3 2023 at Opus Genetics, down from $22000.0 in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $383000.0 in Q3 2021 to a low of $11000.0 in Q3 2023.
  • A 3-year average of $118666.7 and a median of $101000.0 in 2022 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: plummeted 73.63% in 2022, then crashed 89.11% in 2023.
  • Opus Genetics' Short-term Investments stood at $219000.0 in 2021, then crashed by 77.63% to $49000.0 in 2022, then crashed by 77.55% to $11000.0 in 2023.
  • Per Business Quant, the three most recent readings for IRD's Short-term Investments are $11000.0 (Q3 2023), $22000.0 (Q2 2023), and $22000.0 (Q1 2023).